Digital RESI Innovation Challenge

Vote for Me

Interested in Connecting? Please contact:
Andy Lee
COO
lee@vincerebio.com

Message the company or request a 1:1 meeting here

Vincere Biosciences brings decades of research and experience in drug discovery and neurodegenerative disease to discover and develop small molecule therapeutics to slow the progression of age-related diseases. Building on a convergence of human genetics, human tissue experiments, animal models, and our proprietary computational models, Vincere has been able to prioritize molecular switches that improve mitochondrial quality control and health through clearance of damaged mitochondria. Currently in our pipeline are patent-pending, potent, selective inhibitors of USP30 along with an exciting platform of computational, enzymatic, and cell-based assays for discovery and development of small molecule modulators of mitochondrial quality control, a pathway that is well known to degrade with age and that has been linked to multiple age-related diseases.

 

Pitch Video